Novogen Limited
(ASX:NRT) has appointed Dr James Garner as Chief Executive Officer.
The new CEO is currently Head of the Unit Development Office, AP R&D with Sanofi, based in Singapore.
Dr Garner replaces Iain Ross who was appointed Acting CEO in July following the resignation of founder and former CEO, Graham Kelly.
Dr Garner will take up the role on 1 February, at which time he will be appointed to the Board of Directors at Novogen.
Novogen recorded a net loss of $7.3 million at 30 June 2015.
